Copyright Reports & Markets. All rights reserved.

Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Overview

      • 1.1 Product Overview and Scope of Liposome Drug Delivery (Liposomes Drug Delivery)
      • 1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type
        • 1.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Liposomal Doxorubicin
        • 1.2.3 Liposomal Amphoteracin B
        • 1.2.4 Liposomal Paclitaxel
        • 1.2.5 Others
      • 1.3 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
        • 1.3.1 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Fungal Infection Therapy
        • 1.3.3 Cancer & Tumor Therapy
        • 1.3.4 Others
      • 1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market by Region
        • 1.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size
        • 1.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue (2014-2025)
        • 1.4.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2025)

      2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Competition by Manufacturers

      • 2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites, Area Served, Product Types
      • 2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Market Competitive Situation and Trends
        • 2.5.1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Concentration Rate
        • 2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Regions

      • 3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Regions
      • 3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production
        • 3.4.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
        • 3.4.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production
        • 3.5.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2019)
        • 3.6.1 China Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
        • 3.6.2 China Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2019)
        • 3.7.1 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions

      • 4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions
      • 4.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
      • 4.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
      • 4.4 China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
      • 4.5 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)

      5 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price Trend by Type

      • 5.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Type (2014-2019)
      • 5.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Price by Type (2014-2019)
      • 5.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth by Type (2014-2019)

      6 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Analysis by Applications

      • 6.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Liposome Drug Delivery (Liposomes Drug Delivery) Business

      • 7.1 Gilead Sciences
        • 7.1.1 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.1.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Pacira
        • 7.2.1 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.2.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sun Pharmaceutical
        • 7.3.1 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.3.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Johnson & Johnson
        • 7.4.1 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.4.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.4.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Luye Pharma
        • 7.5.1 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sigma-Tau Group
        • 7.6.1 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.6.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Ipsen (Onivyde)
        • 7.7.1 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.7.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.7.3 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 CSPC
        • 7.8.1 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.8.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.8.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Teva Pharmaceutical
        • 7.9.1 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.9.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis
        • 7.10.1 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
        • 7.10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
        • 7.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Fudan-Zhangjiang

      8 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Cost Analysis

      • 8.1 Liposome Drug Delivery (Liposomes Drug Delivery) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Liposome Drug Delivery (Liposomes Drug Delivery)
      • 8.4 Liposome Drug Delivery (Liposomes Drug Delivery) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Distributors List
      • 9.3 Liposome Drug Delivery (Liposomes Drug Delivery) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast

      • 11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast
        • 11.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Price and Trend Forecast (2019-2025)
      • 11.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
        • 11.3.3 China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
      • 11.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
        In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
        North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.

        The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2600 million US$ in 2018 is expected to reach 6040 million US$ by the end of 2025, growing at a CAGR of 12.8% during 2019-2025.
        This report focuses on Liposome Drug Delivery (Liposomes Drug Delivery) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liposome Drug Delivery (Liposomes Drug Delivery) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Gilead Sciences
        Pacira
        Sun Pharmaceutical
        Johnson & Johnson
        Luye Pharma
        Sigma-Tau Group
        Ipsen (Onivyde)
        CSPC
        Teva Pharmaceutical
        Novartis
        Fudan-Zhangjiang

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Liposomal Doxorubicin
        Liposomal Amphoteracin B
        Liposomal Paclitaxel
        Others

        Segment by Application
        Fungal Infection Therapy
        Cancer & Tumor Therapy
        Others

        Buy now